Lack of p62 Impairs Glycogen Aggregation and Exacerbates Pathology in a Mouse Model of Myoclonic Epilepsy of Lafora

Pasquale Pellegrini, Arnau Hervera, Olga Varea, M. Kathryn Brewer, Iliana López-Soldado, Anna Guitart, Mònica Aguilera, Neus Prats, José Antonio del Río, Joan J. Guinovart, Jordi Duran

Research output: Indexed journal article Articlepeer-review

5 Citations (Scopus)

Abstract

Lafora disease (LD) is a fatal childhood-onset dementia characterized by the extensive accumulation of glycogen aggregates—the so-called Lafora Bodies (LBs)—in several organs. The accumulation of LBs in the brain underlies the neurological phenotype of the disease. LBs are composed of abnormal glycogen and various associated proteins, including p62, an autophagy adaptor that participates in the aggregation and clearance of misfolded proteins. To study the role of p62 in the formation of LBs and its participation in the pathology of LD, we generated a mouse model of the disease (malinKO) lacking p62. Deletion of p62 prevented LB accumulation in skeletal muscle and cardiac tissue. In the brain, the absence of p62 altered LB morphology and increased susceptibility to epilepsy. These results demonstrate that p62 participates in the formation of LBs and suggest that the sequestration of abnormal glycogen into LBs is a protective mechanism through which it reduces the deleterious consequences of its accumulation in the brain.

Original languageEnglish
Pages (from-to)1214-1229
Number of pages16
JournalMolecular Neurobiology
Volume59
Issue number2
DOIs
Publication statusPublished - Feb 2022

Keywords

  • Epilepsy
  • Glycogen
  • Lafora bodies
  • Lafora disease
  • Malin
  • Neuroinflammation
  • p62

Fingerprint

Dive into the research topics of 'Lack of p62 Impairs Glycogen Aggregation and Exacerbates Pathology in a Mouse Model of Myoclonic Epilepsy of Lafora'. Together they form a unique fingerprint.

Cite this